Cutaneous expression of CRH and CRH-R. Is there a 'skin stress response system?'

Annals of the New York Academy of Sciences

Volumn 885, Issue , 1999, Pages 287-311

  Slominski, Andrzej T ^a,b   Botchkarev, Vladimir ^c   Choudhry, Mashkoor ^b   Fazal, Nadeem ^b   Fechner, Klaus ^d   Furkert, Jens ^d   Krause, Eberhart ^d   Roloff, Birgit ^d   Sayeed, Mohammad ^b   Wei, Edward ^e   Zbytek, Blazej ^f   Zipper, Josef ^d   Wortsman, Jacobo ^g   Paus, Ralf ^c  

^a LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

^b LOYOLA UNIVERSITY CHICAGO   (United States)

^c HUMBOLDT UNIVERSITY   (Germany)

^d LEIBNIZ INSTITUT FÜR MOLEKULARE PHARMAKOLOGIE   (Germany)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f MEDICAL UNIVERSITY OF GDANSK   (Poland)

^g SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM ION; CORTICOTROPIN RELEASING FACTOR; CORTICOTROPIN RELEASING FACTOR RECEPTOR; CORTICOTROPIN RELEASING FACTOR[9-41]; CYCLIC AMP; DEXAMETHASONE; EGTAZIC ACID; FORSKOLIN; MESSENGER RNA; PROOPIOMELANOCORTIN;

BINDING SITE; CALCIUM CELL LEVEL; CELL CULTURE; CONFERENCE PAPER; DOSE RESPONSE; EXTRACELLULAR CALCIUM; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMMUNOCYTOCHEMISTRY; KERATINOCYTE; MELANOCYTE; NEUROENDOCRINE SYSTEM; NONHUMAN; NORTHERN BLOTTING; RADIOIMMUNOASSAY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SKIN CELL; STRESS; ULTRAVIOLET RADIATION;

EID: 0032763672     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1999.tb08686.x     Document Type: Conference Paper

References (60)

1. 1. Slominski, A. & M. Mihm. 1996. Potential mechanism of skin response to stress. Int. J. Dermatol. 35: 849-851.
2. 2. Slominski, A. & J. Pawelek. 1998. Animals under the sun: effects of ultraviolet radiation on mammalian skin. Clin. Dermatol. 16: 503-515.
3. 3. Slominski, A. et al. 1993. On the potential role of proopiomelanocortin in skin physiology and pathology. Mol. Cell. Endocrinol. 93: C1-C6.
4. 4. McCubbin, J.A. et al. 1991. Stress, Neuropeptides, and Systemic Disease. Academic Press, San Diego.
5. 5. Autelitano, D.J. et al. 1989. Hormonal regulation of POMC gene expression. Annu. Rev. Physiol. 51: 715-726.
6. 6. Fukata, J. et al. 1993. Cytokines as mediators in the regulation of the hypothalamic-pituitary-adrenocortical function. J. Endocrinol. Invest. 16: 141-145.
7. 7. Blalock, J.E. 1989. Molecular basis for bidirectional communication between the immune and the neuroendocrine system. Physiological Rev. 69: 1-69.
8. 8. Lerner, A.B. & J. McGuire. 1961. Effect of alpha-and beta-melanocyte stimulating hormones on the skin color of man. Nature 189: 176-179.
9. 9. Eberle, A.N. 1988. The Melanotropins: Chemistry, Physiology and Mechanism of Action. S. Karger Publ., New York.
10. 10. Pawelek, J. et al. 1992. Molecular cascades in UV-induced melanogenesis: a central role for melanotropins? Pigment Cell Res. 5: 34-356.
11. 11. Luger, T.A. et al. 1998. Cutaneous immunomodulation and coordination of skin stress responses by alpha-melanocyte-stimulating hormone. Ann. N.Y. Acad. Sci. 830: 381-394.
12. 12. Slominski, A. et al. 1992. Melanotropic activity of gamma MSH peptides in melanoma cells. Life Sci. 50: 1103-1108.
13. 13. Slominski, A. & R. Paus. 1993. Melanogenesis is coupled to murine anagen: Toward new concepts for the role of melanocytes and the regulation of melanogenesis in hair growth. J. Invest. Dermatol. 101: 90S-97S.
14. 14. Chakraborty, A. et al. 1996. Production an release of proopiomelanocortin (POMC)-derived peptides by human melanocytes and keratinocytes in culture: Regulation by UVB. Biochim. Biophys. Acta 1313: 130-138.
15. 15. Winzen, M. et al. 1996. Proopiomelanocortin gene product regulation in keratinocytes. J. Invest. Dermatol. 106: 673-678.
16. 16. Wakamatsu, K. et al. 1997. Characterization of ACTH peptides in human skin and their activation of the melanocortin-1 receptor. Pigment Cell Res. 10: 288-297.
17. 17. Can, G. 1998. Identification and sequencing of a putative variant of proopiomelanocortin in human epidermis and epidermal cells in culture. J. Invest. Dermatol. 111: 485-491.
18. 18. Slominski, A. 1991. POMC gene expression in hamster and mouse melanoma cells. FEBS Lett. 291: 165-168.
19. 19. Slominski, A. et al. 1991. Proopiomelanocortin expression and potential function during induced hair growth in C57BL6 mouse. Ann. N.Y. Acad. Sci. 642: 459-462.
20. 20. Slominski, A. et al. 1992. Proopiomelanocortin expression in the skin during induced hair growth in mice. Experientia 48: 50-54.
21. 21. Slominski, A. et al. 1993. Detection of the proopiomelanocortin-derived antigens in normal and pathologic human skin. J. Lab. Clin. Med. 122: 658-666.
22. 22. Slominski, A. et al. 1995. Proopiomelanocortin, corticotropin releasing hormone and corticotropin releasing hormone receptor genes arc expressed in human skin. FEBS Lett. 374: 113-116.
23. 23. Slominski, A. et al. 1996. The expression of proopiomelanocortin (POMC) and of corticotropin releasing hormone receptor (CRH-R) genes in mouse skin. Biochim. Biophys. Acta 1289: 247-251.
24. 24. Slominski, A. et al. 1996. ACTH receptor, CYP11A1, CYP17 and CYP21A2 genes are expressed in skin. J. Clin. Endocrinol. Metab. 81: 2746-2749.
25. 25. Slominski, A. et al. 1996. UVB stimulates production of corticotropin releasing factor (CRF) by human melanocytes. FEBS Lett. 399: 175-176.
26. 26. Ermak, G. & A. Slominski 1997. Production of POMC-, CRH-, ACTH-, and α-MSH-receptor mRNA and expression of tyrosinase gene in relation to hair cycle and dexamethasone treatment in the C57BL6 mouse skin. J. Invest. Dermatol. 108: 160-167.
27. 27. Furkert, J. et al. 1997. Identification and measurement of β-endorphin levels in the skin during induced hair growth in mice. Biochim. Biophys. Acta 1336: 315-322.
28. 28. Roloff, B. et al. 1998. Hair cycle-dependent expression of corticotropin releasing factor (CRF) and CRF receptors (CRF-R) in murine skin. FASEB J. 12: 287-297.
29. 29. Slominski, A. et al. 1998. Characterization of corticotropin releasing hormone (CRH) in human skin. J. Clin. Endocrinol. Metab. 83: 1020-1024.
30. 30. Fazal, N. et al. 1998. Effect of CRF and related peptides on calcium signaling in human and rodent melanoma cells. FEBS Lett. 435: 187-190.
31. 31. Orth, D.N. 1992. Corticotropin-releasing hormone in humans. Endocrine Rev. 13: 164-191.
32. 32. Owens, M.J. & C.B. Nemeroff 1991. Physiology and pharmacology of corticotropin releasing faclor. Pharmacol. Rev. 43: 425-473.
33. 33. Shibahara, S. et al. 1983. Isolation and sequence analysis of the human corticotropin-releasing factor precursor gene. EMBO J. 2: 775-779.
34. 34. Thompson, R.L. 1987. Rat corticotropin-releasing hormone gene: sequence and tissue-specific expression. Mol. Endocrinol. 1: 363-390.
35. 35. Vita, N. 1993. Primary structure and functional expression of mouse pituitary and human corticotropin releasing factors receptors. FEBS Lett. 335: 1-5.
36. 36. Chen, R. et al. 1993. Expression cloning of human corticotropin-releasing factor receptor. Proc. Natl. Acad. Sci. USA 90: 8967-8971.
37. 37. Kishimoto, T. et al. 1995. A sauvagine/corticotropin-releasing factor receptor expressed in heart and skeletal muscle. Proc. Natl. Acad. Sci. USA 92: 1108-1112.
38. 38. Lovenberg, T.W. et al. 1995. Cloning and characterization of a functionally distinct corticotropin-releasing factor receptor subtype from rat brain. Proc. Natl. Acad. Sci. USA 92: 836-840.
39. 39. Liaw, C.W. et al. 1996. Cloning and characterization of the human corticotropin-releasing factor-2 receptor complementary deoxyrubonucleic acid. Endocrinol. 137: 72-77.
40. 40. Li, N. et al. 1992. Skin histoculture assay for studying the hair cycle. In Vitro Cell Dev. Biol. 28A: 695-698.
41. 41. Paus, R. et al. 1991. The epidermal pentapeptide pyroGlu-Glu-Asp-Ser-GlyOH inhibits murine hair growth in vivo and in vitro. Dermatologica 183: 173-178.
42. 42. Rodriguez-Linares, B. et al. 1998. Expression of corticotrophin-releasing hormone receptor mRNA and protein in human myometrium. J. Endocrinol. 156: 15-21.
43. 43. Slominski, A. et al. 1989. MSH inhibits growth in a line of amelanotic hamster melanoma cells and induces increases in cAMP levels and tyrosinase activity without inducing melanogenesis. J. Cell Sci. 92: 551-559.
44. 44. Slominski, A. & R. Paus. 1990. Are L-tyrosine and L-DOPA hormone-like bioregulators. J. Theor. Biol. 143: 123-138
45. 45. Slominski, A. & R. Paus. 1994. Towards defining receptors for L-tyrosine and LnDOPA. Mol. Cell. Endocrinol. 99: C7-C11.
46. 46. Slominski, A. et al. 1993. Melanocytes are sensory and regulatory cells of epidermis. J. Theor. Biol. 164: 103-120.
47. 47. Gjerde, E.A. et al. 1998. Corticotropin-releasing hormone inhibit lowering of interstitial fluid pressure in rat trachea induced by neurogenic inflammation. Europ. J. Pharmacol. 352: 99-102.
48. 48. McLoon, L.K. & J. Wirtschafter 1997. Local injections of corticotropin releasing factor reduce doxorubicin-induced acute inflammation in the eyelid. Invest. Ophthalmol. Vis. Sci. 38: 834-841.
49. 49. Wei, E.T. 1993. Peripheral anti-inflammatory actions of corticotropin-releasing factor. Ciba. Found. Symp. 172: 258-267.
50. 50. Theoharides, T.C. et al. 1998. Corticotropin-releasing hormone induces skin mast cell degranulation and increased vascular permeability, a possible explanation for its proinflammatory effects. Endocrinol. 139: 403-413.
51. 51. Rohde, E. et al. 1996 Corticotropin releasing hormone (CRH) receptors in the mesenteric small arteries of rats resemble the (2)-subtype. Biochem. Pharmacol. 52: 829-833.
52. 52. Thody, T. et al. 1983. MSH peptides are present in mammalian skin. Peptides 4: 813-816.
53. 53. Loir, B. et al. 1997. Immunoreactive α-melanotropin as an autocrine effector in human melanoma cells. Eur. J. Biochem. 244: 923-930.
54. 54. Schauer, E. et al. 1994. Proopiomelanocortin-derived peptides are synthesized and released by human keratinocytes. J. Clin. Invest. 93: 2258-2262.
55. 55. Mountjoy, K.G. et al. 1992. The cloning of a family genes that encode melnocortin receptors. Science 257: 1248-1251.
56. 56. Orel, L. et al. 1997. α-Melanocyte-stimulating hormone down-regulates differentiation-driven heat shock protein 70 expression in keratinocytes. J. Invest. Dertmatol. 108: 401-405.
57. 57. Chakraborty, A. & J. Pawelek. 1993. MSH receptors in immortalized human epidermal keratinocytes: a potential mechanism for coordinated regulation of the epidermal-melanin unit. J. Cell Physiol. 157: 344-350.
58. 58. Holtzmann, H. et al. 1982. Der einfluss ultravioletter strtahlen auf die hypothalamus-hypophysenachse des menschen. Acta Dermatol. 8: 119-123.
59. 59. Holtzmann, H. et al. 1983 Die beemfussung des alpha-MSH durch UVA-bestrahlunger der hautein funktionstest. Hautarzt. 34: 294-297.
60. 60. Paus, R. 1996. Control of the hair cycle and hair diseases as cycling disorders. Curr. Opinion Dermatol. 3: 248-258.